On October 21, on the basis of the trading limit of the previous day, Zhengchuan shares, which had a small and low opening, rose steadily, and rose to 9% during the period. When the market closed (14:44), a large number of sales orders gushed out, smashing the stock price straight down, dropping 9% at the lowest point, and then pulling it up and down again. Finally, it closed down by 8.30% and the intraday amplitude exceeded 18%.
By the end of the day, Zhengchuan shares closed at 86.86 yuan / share, with a turnover rate of 13.88%, a turnover of 2.005 billion yuan and a market value of 13.13 billion yuan. According to the data of Dongfang fortune, as of July 31, this year, there were 43000 shares in the stock. In the list of its top ten circulating shareholders (as of June 30 this year), there were only two institutions, and the remaining eight shareholders were all natural persons.
The netizens of the stock bar cried bitterly: Ive been on guard. Ive earned hundreds of dollars and paid over 70000.
For todays Zhengchuan stock market performance, stock bar netizens burst into a pot, some stock friends exclaimed: heart disease can be scared out, and stock friends today killed: dizzy ah!!! Will the 1000 shares of 98 be on guard? It has been commented that the scenery on the top of the mountain is good! Have stood up straight, there are netizens crying: the list did not see, the final fall when the automatic purchase! What about tomorrow? 102 yuan successfully stood guard, from earning a few hundred yuan to paying more than 70000 yuan. What have I experienced today?.
However, one of the shareholders saw the clue of the main force early. At 10:46 a.m., he made a speech to remind him: today, the turnover rate has reached 6%,... We should pay attention to the risk of main shipment.
There is still uncertainty about whether it can be used as a vaccine
It is worth mentioning that, although it has repeatedly clarified that no relevant orders have been received, Zhengchuan shares, whose main pharmaceutical glass is crowned with the title of vaccine glass bottle, still can not resist the crazy pursuit of investors. The stock price of Zhengchuan shares has been rising since about 13 yuan / share at the beginning of this year. In the middle of June this year, the stock price accelerated to soar, reaching the highest level of 108 yuan / share, and then made a sharp correction. Today, it is full of evil spirit to touch near the early high point again.
The stock price has risen more than three times in half a year, and the real controllers family wealth has increased by 4.2 billion
According to the public information, Zhengchuan Co., Ltd., formerly known as Tangkou glass factory in Jiangbei County, Chongqing, was established in 1989. Since 31 years, the company has been focusing on the R & D, production and sales of pharmaceutical packaging materials such as pharmaceutical glass tube bottles. Its pharmaceutical manufacturing industry accounts for more than 99% of its revenue.
According to the early report, the fortune of Deng Liyong has not yet arrived.
On May 8, the stock price of Zhengchuan shares suddenly started and went straight to the limit on the same day, closing at 18.10 yuan / share. The previous trading day, the stock price was 16.45 yuan / share. To May 13, Zhengchuan shares and closed three consecutive trading board. Since then, the stock price has been surging, sometimes closing one or two limit boards.
Zhengchuan shares was listed on August 22, 2017, with the initial price of 14.32 yuan per share. In 2018, the company implemented the dividend plan of converting 10 shares into 4 shares. On this basis, the stock price on August 4 this year rose 9.63 times compared with the issuing price.
On July 27, the company issued an announcement while Zhengchuan stock price soared. Recently, the company has been concerned about the market rumor about the shortage of vaccine glass bottles reported by the media. At present, the company has not received the relevant batch purchase order. At present, the companys borosilicate tube products are in the stage of technical research and development and have not been formally mass produced. Only through outsourcing, the company produces medium borosilicate glass bottles, and the proportion of medium borosilicate glass bottles in the companys product structure is relatively low. At the same time, according to the current actual situation, even if the company receives the relevant purchase orders in a short period of time, the estimated purchase quantity is relatively limited, and the actual benefit is limited, which will not have a significant impact on the companys operating results.
On September 15, with the concept of vaccine stocks rising again, the stock price of Zhengchuan returned to the upward trend. On September 15, the stock price was up and down, and from September 22 to 24, the stock price was up and down for three consecutive days. In todays session, it rose again to the previous high near 103 yuan / share.
It is worth noting that on the evening of September 24, Zhengchuan Co., Ltd. issued a risk warning announcement again. At present, the company has not received the batch purchase order of relevant vaccine bottles.
That night, Zhengchuan shares also disclosed the shareholders reduction plan.
September 25, A-share market adjustment, individual stocks fell more than rose less. Zhengchuan shares still closed up 2.45%, with a share price of 71.90 yuan / share, a cumulative increase of more than 3.60 times compared with 15.63 yuan / share on March 24 this year.
The sharp rise in the stock price led to a rapid increase in the market value of Zhengchuan shares. As of September 25, the market value of the company was 10.871 billion yuan, an increase of about 8.508 billion yuan compared with March 24. At the end of the second quarter, the companys total assets were 1.305 billion yuan.
Up to now, Deng Yongs family, the actual controller of Zhengchuan shares, directly and indirectly holds 50.27% of the companys shares. As of September 25, the shareholding wealth was 5.465 billion yuan, an increase of about 4.277 billion yuan in half a year.
Performance began to decline last year
The top five largest buyers were 27.202 million yuan from Ping An Securities Co., Ltd. Yinchuan Fenghuang North Street securities business department, 26.782 million yuan from the first securities business department of Tuanjie Road, Lhasa of Dongfang Fortune Securities Co., Ltd., and the remaining business departments were about 20 million yuan. The total net sales of the top 5 buyers and top 5 sellers were 31.9484 million yuan.
It is worth noting that although Zhengchuan is one of the leading enterprises in the domestic pharmaceutical glass tube bottle industry, the companys performance has declined since last year. In 2019, the actual operating revenue was 521 million yuan, a year-on-year decrease of 12.54%; the net profit attributable to the parent company was 61.567 million yuan, with a year-on-year decrease of 26.23%.
In this regard, Zhengchuan Co., Ltd. explained that it was the adjustment of the health care products industry, the orders of some customers in the northeast and northwest regions of the company decreased, and the overall income of the company decreased. At the same time, the demand of foreign customers decreased compared with the previous year.
In the first half of this year, the companys performance further declined under the influence of the epidemic. By the end of June, the actual operating revenue was 256 million yuan, a year-on-year decrease of 4.46%; the net profit attributable to the parent company was 34.92 million yuan, with a year-on-year increase of 9.22%. Every editor noticed that the profitability of Zhengchuan shares has been declining year by year in the past three years. From 2017 to 2019, the gross profit rates are 31.65%, 28.67% and 27.14% respectively. In the first half of this year, the companys gross margin fell to 26.15%. To upgrade its existing production line, Zhengchuan also announced on July 30 that it plans to issue convertible bonds to raise 405 million yuan. Among them, 375 million yuan is planned to be invested in the production project of China borosilicate medicinal glass. (this article is for reference only and does not constitute an investment proposal. Therefore, the operational risk shall be borne by ourselves) source: Daily Economic News Editor: Yang Bin_ NF4368
In the first half of this year, the companys performance fell further under the influence of the epidemic. By the end of June, the actual operating income was 256million yuan, down 4.46% year on year; the net profit attributable to the parent company was RMB 34.92 million, an increase of 9.22% year-on-year.
Every editor noticed that the profitability of Zhengchuan shares has been declining year by year in the past three years. From 2017 to 2019, the gross profit rates are 31.65%, 28.67% and 27.14% respectively. In the first half of this year, the companys gross margin fell to 26.15%. To upgrade its existing production line, Zhengchuan also announced on July 30 that it plans to issue convertible bonds to raise 405 million yuan. Among them, 375 million yuan is planned to be invested in the production project of China borosilicate medicinal glass.
(this article is for reference only and does not constitute an investment proposal. Therefore, the operation risk shall be borne by yourself.)